Cellectar Biosciences, Inc.
CLRB
$2.36
-$0.15-5.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.35M | 13.20M | 12.55M | 11.04M | 13.91M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 920.00K | 842.40K | 1.07M | 1.58M | 987.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 9.27M | 14.04M | 13.62M | 12.62M | 14.89M |
|
|
|||||
| Total Current Assets | 9.27M | 14.04M | 13.62M | 12.62M | 14.89M |
| Net Property, Plant & Equipment | 1.82M | 910.10K | 976.10K | 1.05M | 1.12M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 29.80K | 29.80K | 29.80K | 29.80K | 29.80K |
| Total Assets | 11.12M | 14.98M | 14.63M | 13.70M | 16.04M |
|
|
|||||
| Total Accounts Payable | 4.72M | 1.44M | 4.01M | 4.68M | 3.87M |
| Total Accrued Expenses | -- | 2.48M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 100.20K | 96.00K | 92.00K | 88.10K |
| Total Finance Division Other Current Liabilities | 149.00K | 725.00K | 801.70K | 1.10M | 2.06M |
| Total Other Current Liabilities | 149.00K | 725.00K | 801.70K | 1.10M | 2.06M |
| Total Current Liabilities | 4.87M | 4.75M | 4.91M | 5.87M | 6.02M |
|
|
|||||
| Total Current Liabilities | 4.87M | 4.75M | 4.91M | 5.87M | 6.02M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.53M | 309.40K | 335.90K | 361.50K | 386.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.40M | 5.06M | 5.25M | 6.23M | 6.41M |
|
|
|||||
| Common Stock & APIC | 277.60M | 277.15M | 271.31M | 264.96M | 261.68M |
| Retained Earnings | -274.79M | -269.13M | -263.84M | -259.39M | -253.95M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.81M | 8.02M | 7.48M | 5.56M | 7.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.90M | 1.90M | 1.90M | 1.90M | 1.90M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.90M | 1.90M | 1.90M | 1.90M | 1.90M |
|
|
|||||
| Total Common Equity | 2.81M | 8.02M | 7.48M | 5.56M | 7.73M |
| Total Preferred Equity | 1.90M | 1.90M | 1.90M | 1.90M | 1.90M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.72M | 9.92M | 9.38M | 7.47M | 9.64M |
|
|
|||||